Further studies have suggested that activation of ETAR by ET-1 induces the production of VEGF, which in turn stimulates tumour growth and angiogenesis by increasing the levels of hypoxia-inducible factor-1 (HIF-1α), in a time- and dose-dependent manner (Spinella et al, 2002). Here, VEGFA is linked to neoplasm.